Status:
COMPLETED
Early On-therapy PET at First-line Treatment in Diffuse Large B-cell Lymphoma Stage IIB-IV
Lead Sponsor:
Copenhagen University Hospital at Herlev
Collaborating Sponsors:
Nordic Lymphoma Group
Conditions:
Diffuse Large-Cell Lymphoma
Eligibility:
All Genders
18+ years
Brief Summary
Early identification of refractory lymphoma patients provides a basis for stratification between responders to standard approaches and non-responders who may benefit from an early change to an alterna...
Detailed Description
Title: Evaluation of response to treatment using 18F-FDG positron emission tomography imaging (PET) in diffuse large B-cell lymphoma stage IIB-IV with special emphasize on the prognostic significance ...
Eligibility Criteria
Inclusion
- Age ≥ 18 years.
- Newly diagnosed consecutive patients with diffuse large B-cell lymphoma (DLBCL) according to the WHO classification.
- Ann Arbor stage IIB-IV.
- Written informed consent.
Exclusion
- Previously treated with chemotherapy or irradiation.
- Previous malignant diagnosis except basal cell carcinoma and cervical carcinoma in situ.
- Pregnancy.
- Lactation.
- Diabetes mellitus.
- Extreme adipositas.
- Claustrophobia.
- Active inflammatory disease or infection.
Key Trial Info
Start Date :
August 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2011
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00286832
Start Date
August 1 2005
End Date
January 1 2011
Last Update
July 6 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Hematology, Odense University Hospital
Odense, Denmark, 5000